Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pills

A national medication recall is underway for cetirizine hydrochloride tablets, the generic version of Zyrtec, due to a dangerous packaging error. Unique Pharmaceutical Laboratories initiated this voluntary action after a pharmacy technician discovered foreign pills inside the 5-mg allergy bottles.

The investigation revealed that the allergy tablets may be contaminated with ranitidine, the active ingredient previously found in the heartburn medication Zantac. This cross-contamination presents a risk to consumers who have a known hypersensitivity to ranitidine, as it could trigger severe, life-threatening allergic reactions, including anaphylaxis.

Consumers should check their medicine cabinets immediately for any 5-mg cetirizine hydrochloride tablets purchased recently. The specific lot numbers impacted by this recall are available on the official Food and Drug Administration website. If you possess a bottle matching these lot numbers, you should stop taking the medication immediately.

While no illnesses related to this specific recall have been reported yet, the risk remains significant. Patients with concerns are advised to consult their doctor or healthcare provider. For questions regarding the recall or instructions on how to return the product, contact Rising Pharma Holdings Inc. at 1-844-874-7464 during standard business hours, or send an inquiry via email to their quality assurance or pharmacovigilance teams.

Any adverse health effects experienced after taking the medication should be reported to the FDA through their online portal. Maintaining awareness of these supply chain errors helps ensure personal safety during treatment.